Literature DB >> 32339025

Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.

Ajay J Kirtane1, Sripal Bangalore1.   

Abstract

Entities:  

Keywords:  COVID-19; emergencies; pandemic; percutaneous coronary intervention

Mesh：

Year:  2020        PMID： 32339025     DOI： 10.1161/CIRCOUTCOMES.120.006885

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  4 in total

Review 1.  Case Selection During the COVID-19 Pandemic: Who Should Go to the Cardiac Catheterization Laboratory?

Authors:  Evangelia Vemmou; Ilias Nikolakopoulos; Emmanouil S Brilakis; Payam Dehghani; Santiago Garcia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-18

2.  Fibrinolysis Therapy Combined with Deferred PCI versus Primary Angioplasty for STEMI Patients During the COVID-19 Pandemic: Preliminary Results from a Single Center.

Authors:  Jing Nan; Shuai Meng; Hongyu Hu; Ruofei Jia; Zening Jin
Journal:  Int J Gen Med       Date:  2021-01-19

3.  Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy.

Authors:  Kaiyin Li; Bin Zhang; Bo Zheng; Yan Zhang; Yong Huo
Journal:  Front Cardiovasc Med       Date:  2022-03-17

4.  Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.

Authors:  Jing Nan; Shuai Meng; Hongyu Hu; Ruofei Jia; Wei Chen; Qun Li; Tong Zhang; Ke Song; Yang Wang; Zening Jin
Journal:  Med Sci Monit       Date:  2020-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.